243 related articles for article (PubMed ID: 2219957)
1. Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay.
Embree L; McErlane KM
Xenobiotica; 1990 Jun; 20(6):635-43. PubMed ID: 2219957
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of interference in digoxin immunoassay in renal, hepatic, and diabetic disease.
Tzou MC; Reuning RH; Sams RA
Clin Pharmacol Ther; 1997 Apr; 61(4):429-41. PubMed ID: 9129560
[TBL] [Abstract][Full Text] [Related]
3. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
4. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
[TBL] [Abstract][Full Text] [Related]
5. Comparison of analysis of digoxin in cardiac patients by HPLC and RIA.
Kwong E; Embree L; McErlane KM
Res Commun Chem Pathol Pharmacol; 1990 Apr; 68(1):121-4. PubMed ID: 2345802
[TBL] [Abstract][Full Text] [Related]
6. Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay.
Awni WM; St Peter WL; Guay DR; Kenny MT; Matzke GR
Ther Drug Monit; 1991 Nov; 13(6):511-7. PubMed ID: 1837630
[TBL] [Abstract][Full Text] [Related]
7. Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients.
Anne L; Hu M; Chan K; Colin L; Gottwald K
Ther Drug Monit; 1989 Sep; 11(5):585-91. PubMed ID: 2683253
[TBL] [Abstract][Full Text] [Related]
8. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Matheke ML; Valdes R
Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
Schroeder TJ; Pesce AJ; Hassan FM; Wermeling JR; Warner A; Schlueter KT; First MR
Transplant Proc; 1988 Apr; 20(2 Suppl 2):345-7. PubMed ID: 3284078
[TBL] [Abstract][Full Text] [Related]
10. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
Schlebusch H; Jarausch J; Domke I
Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
[TBL] [Abstract][Full Text] [Related]
11. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
Ng PK; LeGatt D; Coates J; Collins-Nakai RL
Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
[TBL] [Abstract][Full Text] [Related]
12. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].
Jankowski A; Karwowski J; Marzec A; Kretowicz W; Nartowicz E
Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482
[TBL] [Abstract][Full Text] [Related]
13. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].
Sakamoto S; Matsuhisa T; Miyoshi K; Naruse R; Urayama H; Shimokawa T; Okabe K; Toki H; Motoi M; Moriwaki S
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1119-25. PubMed ID: 2053771
[TBL] [Abstract][Full Text] [Related]
14. Improved liquid chromatographic/immunoassay of digoxin in serum.
Stone JA; Soldin SJ
Clin Chem; 1988 Dec; 34(12):2547-51. PubMed ID: 3197300
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
[TBL] [Abstract][Full Text] [Related]
16. Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
Reyes MA; Actor JK; Risin SA; Dasgupta A
Ther Drug Monit; 2008 Feb; 30(1):95-9. PubMed ID: 18223469
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-performance liquid chromatographic-post-column fluorogenic assay for digoxin in serum.
Embree L; McErlane KM
J Chromatogr; 1989 Nov; 496(2):321-34. PubMed ID: 2613836
[TBL] [Abstract][Full Text] [Related]
18. [HPLC, RIA, FPIA. Evaluation of 3 methods for the assay of vancomycin].
Jehl F; Monteil H; Gallion C; Thierry RC
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):511-6. PubMed ID: 3911145
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
Baldelli S; Crippa A; Gabrieli R; Fiocchi R; Perico N; Merlini S; Ottomano C; Cattaneo D
Clin Biochem; 2006 Dec; 39(12):1152-9. PubMed ID: 17054930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
